Dangerous Drugs

Merck & Co., Inc. to Pay $285,000 in Fosamax® Lawsuit, Other Cases Pending

By on February 7, 2013 - Comments off

Over 4,000 lawsuits involving Fosamax®, an osteoporosis drug manufactured by Merck & Co., Inc., are pending in federal and state courts. On February 5, 2013, in Scheinberg v. Merck & Co, Inc., Merck encountered its second loss out of seven cases in which the company will pay $285,000 to the plaintiff, Rhoda Scheinberg.

The 69-year-old plaintiff argued that Fosamax lead to her suffering prolonged healing and a bone disease of the jaw after a tooth extraction. An eight-person jury in U.S. District Court in Manhattan determined that Merck failed to warn the plaintiff’s doctors about the risks of taking Fosamax and that this failure to warn caused the plaintiff’s injury. However, the plaintiff’s claim that Fosamax is a defective product was denied by the jury.

Merck noted in a statement that it does not agree with the verdict and stated that the jury produced a mixed verdict.

Read the rest »

Posted in: Fosamax®